SAN FRANCISCO — In this video from Glaucoma 360 New Horizons Forum, Thurein Htoo, MS, MBA, CEO of Qlaris Bio, discusses the importance of lowering episcleral venous pressure, or EVP.
“Some might appreciate EVP as being the largest component of intraocular pressure, but it so happens to be also the only component of intraocular pressure that is not completely targeted by the therapies available on the market right now,” he said.
SAN FRANCISCO — In this video from Glaucoma 360 New Horizons Forum, Thurein Htoo, MS, MBA, CEO of Qlaris Bio, discusses the importance of lowering episcleral venous pressure, or EVP.
“Some might appreciate EVP as being the largest component of intraocular pressure, but it so happens to be also the only component of intraocular pressure that is not completely targeted by the therapies available on the market right now,” he said.
